Pharma

Your Article Summary

See Latest Articles

Watson Announces Limited Recall Of Fentanyl Transdermal System
Watson Pharmaceuticals, 08/10/09

Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that one lot of 100 mcg/hr Fentanyl Transdermal System patches sold in the United States is being voluntarily recalled from wholesalers and pharmacies. The recalled patches are from Lot Number 145287A, have expiration dates of February 2011 and were manufactured by Watson Laboratories, Inc. and distributed by Watson Pharma, Inc. The affected lot of Fentanyl Transdermal System patches was shipped to customers between April 2009 and May 2009. No other strengths or lots were affected and the Company does not anticipate any product shortages as a result of this recall.

Today in Regulatory Issues...keeping you current

Receive free subspecialty "5-minute updates" via email

Two Delivery Systems Win Baldrige Award
HealthDataManagement, 12/17/09

Advisory Committee briefing materials for CRESTOR sNDA available on US FDA web site
AstraZeneca, 12/15/09

Sixteen Fired for Records Snooping
HealthDataManagement, 12/09/09

 See all of Regulatory Issues